Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
2,425,154
-
Share change
-
-141,658
-
Total reported value
-
$1,213,076
-
Price per share
-
$0.50
-
Number of holders
-
20
-
Value change
-
-$48,085
-
Number of buys
-
6
-
Number of sells
-
14
Institutional Holders of GALMED PHARMACEUTICALS LTD - SHS (GLMD) as of Q4 2022
As of 31 Dec 2022,
GALMED PHARMACEUTICALS LTD - SHS (GLMD) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,425,154 shares.
The largest 10 holders included
BVF INC/IL, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, RAYMOND JAMES & ASSOCIATES, Western Wealth Management, LLC, Cambridge Investment Research Advisors, Inc., Raymond James Financial Services Advisors, Inc., JANE STREET GROUP, LLC, GEODE CAPITAL MANAGEMENT, LLC, and UBS Group AG.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.